Home / Health / Autoimmune Disease Raises Cancer Risk, But Relief Found
Autoimmune Disease Raises Cancer Risk, But Relief Found
6 Apr
Summary
- Autoimmune diseases increase cancer risk by 32% in the first year.
- Anti-inflammatory medications reduce cancer risk for patients.
- Chronic inflammation, not treatments, is key to cancer development.
Individuals diagnosed with autoimmune diseases such as lupus, rheumatoid arthritis, or psoriasis experience a heightened risk of developing cancer. A recent study found this increased likelihood to be 32% in the initial year following an autoimmune diagnosis.
However, the outlook improves as patients initiate treatment with anti-inflammatory medications designed to manage the excessive inflammation characteristic of these conditions. This therapeutic intervention leads to a reduction in their cancer risk.
The peak cancer risk observed in the early stages of autoimmune disease suggests that persistent inflammation plays a crucial role in the genesis of cancer. This contrasts with the notion that treatments themselves are the primary cause.
Cancers of the lung and bladder, along with blood malignancies like leukemias and lymphomas, and melanoma were found to be most associated with autoimmune disease. These findings support the hypothesis that inflammation is a significant determining factor in cancer risk.
Consequently, there is a strong emphasis on encouraging cancer screening for individuals diagnosed with autoimmune diseases. This is particularly vital during the first year after their diagnosis to detect any potential malignancies early.
